Understanding The Role of ALDH18A1 in Fatty Acid Biosynthesis

Target Name: ALDH18A1

NCBI ID: G5832

ALDH18A1

Understanding The Role of ALDH18A1 in Fatty Acid Biosynthesis

ALDH18A1 (delta-1-pyrroline-5-carboxylate synthetase) is an enzyme involved in the synthesis of a fatty acid, which is a crucial molecule in many cellular processes. The structure and function of this enzyme have been extensively studied, and its role in various biological processes have been identified. Additionally, recent research has suggested that ALDH18A1 may be a drug target or biomarker, which could have implications for the development of new therapeutic approaches.

ALDH18A1 is an enzyme belonging to the superfamily of 18S rRNA-protein interactions (SRPI) that is present in various organisms, including humans. This enzyme is responsible for catalyzing the synthesis of the linear fatty acid, 18-methyl-docosahexaenoic acid (18- MDE). The production of 18-MDE is a critical step in the biosynthesis of arachidonic acid, which is a potent signaling molecule that regulates various cellular processes, including inflammation, hormone signaling, and cell signaling.

The primary function of ALDH18A1 is to catalyze the synthesis of 18-MDE from the starting material, such as acetyl-CoA and pyruvate. The enzyme uses a series of substrate-binding sites to recognize and activate the starting materials. The first substrate is acetyl -CoA, which is a carbon source for many cellular processes. The second substrate is pyruvate, which is a critical carbon source for the synthesis of many essential amino acids and nucleotides. The third substrate is CoA, which is a precursor for the synthesis of fatty acids.

The synthesis of 18-MDE from these substrates is a critical step in the biosynthesis of many essential fatty acids, including arachidonic acid, which is a potent signaling molecule. Arachidonic acid is involved in the regulation of various cellular processes, including inflammation, hormone signaling , and cell signaling. It also plays a crucial role in the production of cell membrane, bile, and other biological compounds.

In addition to its role in fatty acid biosynthesis, ALDH18A1 has also been shown to have other functions. For instance, ALDH18A1 has been shown to be involved in the regulation of cellular processes, including cell signaling, cell growth, and apoptosis. The enzyme has has been shown to play a role in the regulation of cell signaling pathways, including the TGF-β pathway, which is involved in cell growth, differentiation, and survival.

Moreover, recent studies have suggested that ALDH18A1 may be a drug target or biomarker. The development of new therapeutic approaches for ALDH18A1 could have implications for the treatment of various diseases. For instance, the synthesis of 18-MDE is a critical step in the biosynthesis of arachidonic acid, which is involved in the regulation of various cellular processes, including inflammation. Therefore, inhibition of ALDH18A1 could be a potential therapeutic approach for the treatment of inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, and cancer.

In conclusion, ALDH18A1 is an enzyme involved in the synthesis of a crucial molecule in many cellular processes, 18-MDE. The structure and function of this enzyme have been extensively studied, and its role in various biological processes have been identified. Additionally, recent research has suggested that ALDH18A1 may be a drug target or biomarker, which could have implications for the development of new therapeutic approaches. Further research is needed to fully understand the role of ALDH18A1 in cellular processes and its potential as a drug target or biomarker.

Protein Name: Aldehyde Dehydrogenase 18 Family Member A1

Functions: Bifunctional enzyme that converts glutamate to glutamate 5-semialdehyde, an intermediate in the biosynthesis of proline, ornithine and arginine

The "ALDH18A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ALDH18A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets